Effect of chronic infusion of epoprostenol on echocardiographic right ventricular myocardial performance index and its relation to clinical outcome in patients with primary pulmonary hypertension.
Sebbag
I
I
Echocardiography Laboratory, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
Rudski
L G
LG
Therrien
J
J
Hirsch
A
A
Langleben
D
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015150:Echocardiography, Doppler; D011464:Epoprostenol / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006352:Heart Ventricles / Q000000981:diagnostic imaging*; D006439:Hemodynamics; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D016278:Ventricular Function, Right / Q000187:drug effects*
D000959:Antihypertensive Agents; D011464:Epoprostenol